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INTRODUCTION
The epilepsies are among the most common of neuro-
logical disorders, prevalence is about 1%1; based on
this figure, there are 500 000 people in the UK who
suffer from epilepsy. Approximately 70% of patients
with epilepsy are well controlled by monotherapy with
currently available antiepileptic drugs2. Another 5–
10% of patients are stabilized by the addition of an-
other antiepileptic drug but there remains over 20% of
patients whose seizures are not controlled2. By estima-
tion, in the UK alone, 100 000 patients with epilepsy
require more effective antiepileptic drug treatments.
The last 10 years have been an exciting time for
both patients with epilepsy and the health profession.
Five new antiepileptic drugs, gabapentin, lamotrigine,
tiagabine, topiramate and vigabatrin, have been mar-
keted in the UK and other countries. They have all
been shown to be effective in short-term add-on clini-
cal trials in patients with uncontrolled epilepsy. How-
ever, in long-term study, Wong showed that less than
a quarter of patients with severe epilepsy will still be
taking the new antiepileptic drugs (gabapentin, lam-
otrigine and vigabatrin) after six years, few patients
will be seizure free3. He concluded that the task to im-
prove the prognosis of severe epilepsy has not been
accomplished. Therefore, phytomedicines can poten-
tially play an important role in the development of new
antiepileptic drugs.
Many plants were known for their anticonvulsant
activity. Various phytochemical and pharmacological
studies have been carried out on these anticonvul-
sant plants. In fact, a review article4 was previously
published with regards to plants with anticonvulsant
activity. Thus, the aim of this article is to give an
up-to-date literature review on plants/natural products
which have been used traditionally for the treatment
of epilepsy or those which have been shown to pos-
sess anticonvulsant activity.
MATERIALS AND METHOD
An extensive literature search was carried out in 1999
using the Science Citation Index of BIDS (Bath In-
formation Data Services), 1981 to date and PubMed
(Medline), 1966 to date. The keywords used in the
search were: Epilepsy, Plant, Anticonvulsant, Natural
product, Antiepileptic, Herbal, Seizure, Traditional,
Remedies. From the literature search, all plants/herbal
preparations that are used ethnomedically to treat
epilepsy or those which have been tested for anticon-
vulsant activity are included in this review.
RESULTS
Over 50 references were found in which plants or
herbal preparations have been tested for their anticon-
vulsant activity in in vivo/in vitro studies (see Table 1)
or clinical studies (see Table 2).
DISCUSSION
Models for testing antiepileptic drugs
Seizures can be induced in animals by a wide range of
experimental methods such as electrical or chemical
stimulation. The choice of a particular model depends
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Table 1: In vivo/in vitro studies on antiepileptic plants.
This table comprises an extensive list of plants (arranged in alphabetical order) used ethnomedically to treat epilepsy/convulsion or in some
way tested for therapeutic activity against epilepsy. The following explains the abbreviations used in the table.
Plants:- The scientific names (in Latin binomials) of the plants are given as they appear in the references. The family in which the plants
belong to are given in brackets.
HP:- Herbal preparations. In some studies, instead of testing on one single plant, the effects of herbal preparations (which consist of several
plants) were investigated.
ETH:- Ethnic origin. The name of the countries in which the plant is used traditionally to treat epilepsy is given.
PT:- Part of the plant tested.
Abbreviations: ap, aerial parts; bk, bark; bl, bulb; fl, flower; fr, fruit; j, juice; lf, leaf; pl, peel; rb, root bark; rt, root; rz, rhizome; sb, stem
bark; sd, seed; sh, shallot; sho, shoots; st, stem; stk, stalk; tb, tuber; wd, wood; wp, whole plant (roots, stems, leaves and flowers).
ROA:- Route of administration.
Abbreviations: ip, intraperitoneal; iv, intravenous; po, per os (orally); sc, subcutaneous.
Activity:- Anticonvulsant/Anti-epileptic activity
Keys: +: active; −: inactive; ↑: increase/stimulate; ↓: decrease/inhibit; ACV, anticonvulsant effect; AEP, Anti-epileptic effect; AIC,
acetylcholine-induced convulsions; AUIS, audiogenic-induced seizures; ChIC, chemo-induced convulsions; CMIC, champhor-induced
convulsions; CZIC, corazole-induced convulsions; DIA, dependent inhibiting action; EEG, electroencephalogram, EIC, electrically-
induced convulsions; GABA, γ -aminobutyric acid; HIC, histamine-induced convulsions; KAIC, kainic acid-induced convulsions; LIS,
leptazole-induced seizure; MES, maximum electroshock seizures; MIS, metrazole-induced seizures; 3-MCAIC, 3-mercaptopropionic
acid-induced convulsions; NMDLAIC, N-Methyl-DL-aspartate-induced convulsions; NMDAMN, N-Methyl-D-aspartate acid-mediated
neurotransmission; PIC, picrotoxin-induced convulsions; PLIC, pilocarpine-induced convulsions; PTZ, pentylenetetrazole; PZIC,
pentylenetetrazole-induced convulsions; SIS, strychnine-induced seizures; TCES, transcorneal electroshock.
ACWSD:- Activity compared with synthetic drugs. A comparison in the potency of activity with synthetic drugs currently used in the market.
Keys: >: more than; <: less than; =: equal to; ADE, antidiarrhoeic effect; BND, benzodiazepine; DPR, desipramine; DZ, diazepam;
LOP, loperamide; PB, phenobarbitone; PHT, phenytoin; TMP, trimipramine; VA, valeproic acid.
TM:- Testing models. vv: in vivo; vt: in vitro.
Animals species used: am, albino mice; ar, albino rats; gp: guinea pigs; mk: monkeys; m: mice; r: rat; sm: swiss mice; wch: white
chicks; wm: wister mice; wr: wister rats
apls, anterior part of left side; b, brain; cc, cortical cortex; cw, cortical wedges; hs, hippocampal slices; igp, ileum of guinea pigs; sc,
spinal cortex; tram, toad rectus abdomen muscular; ts, tactile stimulation.
AE/C (Active extracts/constituents):- Plants extracts or constituents that have been tested for anticonvulsant activity.
Keys: AE, alcoholic extract; AEO, aromatic essential oil; Alk, alkaloid; Alk E, alkaloidal extract; Aq E, aqueous extract; ASFA, aqueous
solution of mixed fatty acids; BE, boiled extract; 6-BZH, 6-Benzoylheteratisine; 1-BZN, 1-benzoylnapelline; ChE, chloroform extract;
E, extract; EE, ethanolic extract; EO, essential oil; HC, hydroalcoholic extract; IP, imperatarin; LAE, lyophilised aqueous extract; ME,
methanolic extract; NEO, neutral essential oil; SDE, steam distillate extract; SP, scoparone; WE, water extract; VDA, vacuum dried
aqueous extract; Xn, xanthoxyletin.
SE/Tox:- Possible side effects or toxicity data reported.
Keys: AX, ataxia; BC, behavioural changes; CNSD, central nervous system depressant; CNSS, central nervous system sedative; D,
depression; HA, hypnotic action; HG, hypoglycaemic; HP, hypothermic; HPT, hypotension; PB, phenobarbitone; RMA, reduced motor
activity; S, sedative; TE, transient excitation; TS, transient stimulation.
REM (Remarks):- Other activities reported.
Keys: A, analgesic; AB, antibacterial; AC, anticancer; AD, antidepressant; ADE, antidiarrhoeic effect; AHT, antihypertensive; AI,
anti-inflammatory; AM, antimalarial; AMG, antimigraine; AN, anthelmintic; ANX, anxiolytic; AP, antipyretic; AR, antiarrhythmic; B,
bactericidal; CBRL, central benzodiazepine receptor ligand; F, fungicidal; HNC, hypnotic; HYM, hypomotility; IE, initial excitation;
IT, intestinal transient; MR, muscle relaxant; NAX, no ataxia; NBA, neuromuscular blocking agent; NCNSD, no CNS depressant;
NMR, no muscle relaxant; NRP, neuroleptic; PTS, ptosis; TQ, tranquillizing
RN:- References as in the reference section.
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Plants HP ETH PT ROA Activity ACWSD TM AE/C SE/Tox REM RN
Abrus precatorius L. — India rt — + LIS — — — S — 5
(Leguminosae) − SIS CNSD
Aconitum species — China — iv DIA/central neurons = DZ vt/hs 1-BZN, — — 6
(Ranunculaceae) 6-BZH 7
Acorus calamus — — — — +MIS — — AEO,NEO — — 4
(Araceae)
Adonis vernalis — — — — + ACV — — — — — 4
(Ranunculaceae)
Afraegle paniculate — Nigeria st,rt ip + LIS, + ACV — vv/m ME S A,AP 4, 5
(Rutaceae) CNSD
Albizia lebbek Benth. — India rt,lf ip ++ PIC, PZIC — vt/b Chloroform — — 5
(Leguminosae) +MIS, ↑ GABA vv/am fraction of 8
level in the brain ME
Albizia zygia Macribide — Africa lf po − LIS — — — — — 5
(Leguminosae) − SIS
Allium ascalonicum — — sh — + LIS — — AE HPN A 5
(Liliaceae)
Allium cepa L. (onion) — — bl — + LIS — — AE HPN A,B 5
(Liliaceae) − SIS
Allium sativum L. (garlic) — — bl — + LIS — — AE HG,HPT AB,B 5
(Liliaceae) S AN,F
Alstonia boonei D.Wild — Nigeria sb — + LIS — — AE — CNSD 5
(Apocynaceae) Echitamine S
Alstonia schoaris R.Br. — India sb — — — — Alk HPT AM,AC 5
(Apocynaceae) NBA
Annona muricata L. — — fr po − LIS — — — — — 5
(Annonaceae) − SIS
Apium graveolens — — — — + ACV — — — — — 4
(Umbelliferae)
Areca catechu — — — iv ↓ uptake of — vt/sc Arecaidine — — 9
(Palmae) sc GABA & Guvacine
β-alanine




Asparagus officinalis — — — — + LIS — — — — — 4
(Liliaceae)
Astragalus centralpinus — — — — +BaCl2, AIC — — — — — 4
(Leguminosae) HIC
Atractylodes lancea — China — ip +MIS = PHT vt/hs β-eudesmol — — 11




Baccharis serraefolia — Mexico lf po Significantly ADE = LOP vv/m — — ADE 12





Basslla alba L. — India lf,st — − LIS — — AE S,CNSD — 5
(Basellaceae) − SIS
Basslla ruba L. — India lf,st — − LIS — — AE S,CNSD — 5
(Basellaceae) − SIS
— Brahmighritham, po + PZIC = BND vv/ar — — — 13
an Ayurvedic
herbal formula:
Herpestis monniera L. India lf,st
(Scrophulariaceae)
Cyperus rotundus L. India & tb
(Cyperaceae) Cylon
Saussurea lappa Clarke Himalaya tb
(Asteraceae) & Kashmir
Ghee (dehydrated form of
butter)
— Brahmi Rasayan, — po + EIC, — vv/m, — S, AC 14
an Ayurvedic herbal + ChlC r ↑ HA
formula: of PB
Herpestis monniera L. lf
(Scrophulariaceae)
Eugenia caryophyllata Thunb. fl
(Myrtaceae)
Piper longum L. stk
(Piperaceae)
Elettaria cardamomum Maton sd
(Zingiberaceae)
Caesalpinia bonduc — — rt,sd — + LIS, — — — — — 5
(Leguminosae) + SIS
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Plants HP ETH PT ROA Activity ACWSD TM AE/C SE/Tox REM RN
Calliandra portori- — Africa, rt,st ip ++ LIS, — — AqE, S A 5
censis Nigeria ++ SIS, Alk E 15
(Leguminosae) +MIS
Cannabis sativa — — — — + ACV — — Cannabinoid — — 4
(Cannabinaceae)
Canscora decussata — — wp po + ACV <PHT vv/ar AE — — 16
(Gentianaceae) ChE 4
Capparis baduca — — — — + ACV — — Alk — AI 4
(Capparaceae)
Capsicum annum L. — — fr — − LIS — — — — — 4
(Solanaceae) − SIS
Carica papaya L. — — rt — + LIS — — E — — 5
(Caricaceae) + SIS
Casimiroa edulis — Mexico lf po +MIS =PHT, vv/wr VDA — — 17
(Rutaceae) sc PB
Centella asiatica L. — — — — − LIS — — AE S — 5
(Umbelliferae) − SIS Alk
Cerbera odollam — Vietnam, lf ip + PZIC — vv/m — Potentiated PB A 18
(Apocynaceae) Cambodia hypnotic effect
Cinchona officinalis — — — — + ACV — — Quinine — — 4
(Rubiaceae)
Cissampelos pareira L. — — rt — + LIS — — Alk CNSD, S — 5
(Menispermaceae) + SIS
Citrus aurantifolia — — fr — − LIS — — Citral CNSD — 5
(Rutaceae) − SIS (lime)
Citrus aurantium L. — — pl — ++ LIS — — EO CNSD — 5
(Rutaceae) + SIS





Cleome cileata — Nigeria lf ip ++MIS — vv/am Aq E CNSD — 20
(Capparidaceae) + PZIC
Cnestis glabra — — — — + ACV — — Glabrin — — 4
(Connaraceae)
Cola acuminata L. — — sb,fr — − LIS — — — TS followed — 5
(Sterculiaceae) − SIS by D
Convolvulus arvensis — — — — + ACV — — — — — 4
(Convolvulaceae)
— Cow’s urine concoction Nigeria ip − ACV — vv/am ChE Reduce tone — 21
Nicotiana tabacum lf of smooth
(Solanaceae) muscles,
Ocimum viride lf HPT,
(Lamiaceae) CNSD, HP,
Citrus limon j HG, loss of
(Rutaceae) vasoconstr-
Allium sativum lf uctor tone,
(Liliaceae) cardiac
Allium cepa & bl depression




Cucurbita pepo L. — — — — − LIS — — — — — 5
(Cucurbitaceae) − SIS
Cymbopogon citratus — Brazil lf po − ACV — vv/m, EO HP ↓ IT 22
(Gramineae) ip r
Cynodon dactylon L. — Nigeria lf ip + PZIC, MIS — vv/am Aq E CNSD, — 5, 20
(Gramineae) AX
Cyperus articulatus — Africa, rz po Inhibited spontaneous — vv/m, WE — — 23
(Cyperaceae) L.America epileptiform discharge r
↓NMDAMN vt/cw
Cyperus rotundus L. — — rt — + LIS, SIS — — AE — — 5
(Cyperaceae)
Delphinium consolida — — — — + ACV — — — — 4
(Ranunculaceae)
Desmodium adscendens — Africa lf ip + PZIC, KAIC — vv/ EE HP A 24
(Leguminosae) −MIS sm,
wr
Duboisia leichhardtii — — — — + ACV — — — — — 4
(Solanaceae)
Echinacea purpurea — — — — + ACV — — — — — 4
(Asteraceae)
Echium vulgare — — — — + ACV — — E — — 4
(Boraginaceae)
Egletes viscosa L. — Brazil fl po + PZIC — vv/m EO — A, AB 25
(Asteraceae) (S.aureus)
Elaeocarpus ganitus Roxb. — — sd po +MES, −MIS — vv/am EE — — 26
(Elaeocarpaceae) ASFA
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Plants HP ETH PT ROA Activity ACWSD TM AE/C SE/Tox REM RN
Eryngium feotidum L. — Jamaica, lf,st ip + PIC =PB vv/r Aq E — — 27
(Umbelliferae) Caribbean, BE
S.America SDE
Erythroxylum spp. — — — — +MIS — — Cocaine — — 4
(Erythroxylaceae)
Euphorbia hirta L. — — wp ip − ACV — vv/m, LAE S A, 28
(Euphorbiaceae) r AD
Euphorbia pilulifera — — — — Monotoxic and — vv/gp — — — 4
(Euphorbiaceae) prophylactic action
against lethal egg-white
shock in guinea pigs
Galicia spp. — — — — + ACV — — — — — 4
(Galiaceae)
Galium cruciata — — — — Folk medicine — — — — — 4
(Rubiaceae)
Galium sylvaticum — — — — Folk medicine — — — — — 4
(Rubiaceae)
Galphimia glauca — Mexico ap ip − ACV — vv/am ME: S, — 29
(Malpighiaceae) Galphimine B CNSD
Gastrodia elata — — — — + ACV — — — — — 4
(Orchidaceae)
Ginkgo biloba — Africa — po ↓ ECS induced diacyl- — vv/wr E — — 30
(Ginkgoaceae) glycerols and fatty acids cc,hs
accumulation; selective
sites of drug action in CNS
Haplophyllum perforatum — — sd — + CZIC, CMIC — — — — — 4
(Rutaceae)
Haplophyllum lociosum — — — — + LIS, CZIC — — — — — 4
(Rutaceae)
Haplophyllum spp. — — — — + ACV — — — — — 4
(Rutaceae)
Heracleum sibiricum — — — — + EIS, PZIC, CZIC — — — — — 4
(Umbelliferae) − SIS
Heracleum verticillatum — — — — +MES, PZIC, CZIC — — — — — 4
(Umbelliferae) − SIS
Herpestris monniera — — — — — — — — — TQ 4
(Scrophulariaceae)
Holarrhena floribunda — Nigeria lf ip + PZIC, MIS — vv/am Aq E CNSD, — 20
(Apocynaceae) AX
Hypericum calycinum L. — Greece, wp ip — = DPR, TMP vv/m E — AD 31
(Hypericaceae) Romania
Hypericum perforatum L. — Greece, wp ip — = DPR, TMP vv/m E — AD 31
(Hypericaceae) Romania
Ipomoea stans — Mexico wd iv + EIC, PZIC (after = VA vv/am — — — 32
(Convolvulaceae) long-term treatment)
Jatropha curcas L. — — rt — ++ LIS, + SIS — — — — — 5
(Euphorbiaceae)
Jatropha gossypiifolia L. — — rt, lf — + LIS, SIS — — — S, CNSD — 5
(Euphorbiaceae)
Kochia prostrata — — — — + SIS — — EE — — 4
(Chenopodiaceae)
Lanata camara L. — — rt,lf iv + LIS, SIS — vv/m EO CNSD F 5
(Verbenaceae) AE
Lanata microphylla — Brazil lf — + LIS, SIS — vv/m EO CNSD F 5
(Verbenaceae) AE
Leonurus cardiaca — — — — + ACV — — — — — 4
(Lamiaceae)
Liacaria puchurymajor — — — — + TCES — — EO RMA — 4
(Lauraceae)
Lonchocarpus sericeus — — rt — − LIS, SIS — — — CNSD — 5
(Leguminosae)
Magnolia officinalis — China bk ip Prevent tonic — vv/am Magnolol AX, S HYM, 4, 33
(Magnoliaceae) Japan extensor wch, Honokiol CNSD PTS, MR
convulsions wr
Magnolia obovata — — — — + SIS, + PIC, — — — — AB 4
(Magnoliaceae) + PZIC
Marsilea rajasthanesis — — — — + ACV, AEP — — — — — 4
(Marsileaceae)
Marrubium vulgare — — lf, fl — — — — — — AMG 4
(Lamiaceae)
Maprounea africana — Congo lf ip Delayed the onset — vv/sm — HP ↑ HA 34





Matricaria recutica L. — Europe fl iv − PZIC — vv/m Apigenin S CBRL, 35
(German Chamomile) US ANX
(Asteraceae)
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Maytenus spp. — Brazil lf po, − TCES, ChIC — vv/sm WE CNSD HNC 36
(Celastraceae) ip r (ip only) (ip only)
Melia azedarach L. — — rb — ++ SIS, LIS — — — S, CNSD — 5
(Meliaceae)
Momordica balsamina L. — — lf, — − LIS, SIS — — — CNSD — 5
(Cucurbitaceae) fr
Momordica charantia L. — — sho, — − LIS, SIS — — — CNSD — 5
(Cucurbitaceae) lf, fl
Moringa oleifera Juss. — — rt — ++ SIS, LIS — — — S, CNSD — 5
(Moringaceae)
Nardostachys jatamansi — — — — + ACV — — — — AR 4
(Valerianaceae)
Newboldia leavis — Nigeria lf ip + PZIC, MIS — vv/am Aq E CNSD, — 20
(Bignoniaceae) AX
Nicotiana tabacum L. — — — — ++ SIS, LIS — — AE S, IE, A 5
(Solanaceae) CNSD
Ocimum americanum L. — — lf — ++ LIS — vv/m — S, — 5
(Lamiaceae) CNSD
Ocimum basilicum L. — — lf — ++ LIS — vv/m — S, A 5
(Lamiaceae) CNSD
Ocimum gratissimum L. — — — — + LIS — vv/m AE S, CNSD A 5
(Lamiaceae) − SIS
Paeonia radix J.P. — Japan rt po + ACV; — vt/apls WE, — — 37
(Paeoniaceae) protective effect on Gallo-
neuron damage tannin
Panax ginseng C.A. — China lf, rt ip −MIS, PIC — — — — NRP, 4, 38
(Araliaceae) A, AP
Patrina intermedia — — — — + SIS — — — — — 4
(Valerianaceae)
Pausinystalia yohimbe — — bk ip + ACV — vv/m; Yohimbine — — 39
(Rubiaceae) (antagonised by prior ts (indole
administration of alkaloid)
clonidine or prazosine
Picnomon acarna — — — — + ACV — — Alk S — 4
(Asteraceae)
Piper guineense L. — Nigeria fr ip + AUIS, MIS & = PB vv/m WE, — NCNSD 40
(Piperaceae) NMDLAIC, EE
− PZIC
Piper methyticum — — — — + SIS — — — — — 4
(Piperaceae)
Piper nigrum L. — China fr — + ACV — vv/m WE — — 4, 41
(Piperaceae) (an antagonistic action vt/cw
at N-methyl-D-aspartic
acid receptors)
Pithecellobium saman — — — — + PIC, AUIS — — Alk — — 4
(Leguminosae)
Plumbago zeylanica L. — — rt — + LIS — — — S A, AB 5
(Plumbaginaceae)
Portulaca oleracea L. — — wp — − LIS, SIS — — — — — 5
(Portulacaceae)
Psidium guyanensis Pers — Brazil lf po + PIC, SIS, PZIC = PB vv/sm EO — — 42
(Myrtaceae) & AIC (20 mg/kg) vt/tram
Qingyangshen — China rt ip + AEP, — vv/wr — — — 43, 44,
(root of Cynanchum ↓ KAIC vt/b, hs 45, 46
otophylum Schnchid, of
family Asclepiadaceae)
Rauwolfia schueli — — — — — — — — — — 5
(Apocynaceae)
Rauwolfia serpentina — — rt, — — — vv/mk Reserpine — ANX 4,5
(Apocynaceae) sb AHT
Rauwolfia vomitoria Afz — — — — + LIS, SIS — vv/m Alk S, CNSD A 5
(Apocynaceae) & BC
Ricinus communis L. — — rt, sd — + LIS — — — — — 5
(Euphorbiaceae) − SIS
Roylea elegans — — — ip + ACV — — EE, CNSD — 4
(Lamiaceae) WE
Ruta chalepensis — Mexico lf, ip + PZIC, EIC — vv/m ME, ↑ HA — 47
(Rutaceae) USA, st vt/igp AE of PB
Africa, (ap)
Asia
Salvia guaranitica — Latin ap ip − ACV — vv/m Cirsiliol S HNC, 48
St. Hill America − ANX,
(Lamiaceae) −MR
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Salvia nemorsa — — — — + ACV — — E — — 4
(Lamiaceae)
— Saiko-keishi-to (SK) or Japan — po + ACV; = PHT vv/wr, — — — 49, 50,
TJ-960, a Japanese preventive effect against r 51, 52,
Kampo herbal medicine neuron damage; vt/hs, b 53
consisting of a mixture activates GABAA
of 9 herbal drugs: receptors;
Paeonia radix Paeonia radix showed
(Paeoniaceae) statistically significant
Cinnamomum cortex inhibition of PTZ
(Lauraceae) induced EEG power














Solanum americana Jacq. — — fr, lf — + ACV, LIS — — Scopoletin CNSD, S A 5
(Solanaceae)
Solanum dasyphullum — — — — — — — — — — 4
(Solanaceae)
Solanum gilo Raddi — — fr — ++ LIS, — — — — — 5
(Solanaceae) + SIS
Solanum indicum L. — — fr — + LIS — — — — — 5
(Solanaceae) − SIS
Solanum macrocarpon L. — — fr, lf — − LIS, SIS — — — — — 5
(Solanaceae)
Solanum melongena L. — — fr, lf — ++ LIS, — — Scopoletin — — 5
(Solanaceae) + SIS Scoparone
Solanum nigrum L. — — — — + LIS & SIS — — AE TS followed — 5
(Solanaceae) by D & HPT
Solanum torvum Swartz — — fr — + LIS — — TE followed — 5
(Solanaceae) by D
Spondias monbin L. — — fr — − LIS, SIS — — — — — 5
(Anacardaceae)
Spondias monbin L. — — fr — − LIS, SIS — — — — — 5
(Anacardaceae)
Talinum triangulare Wild — — wp — − LIS, SIS — — — — — 5
(Portulacaceae)
Taraxacum spp. — — — — + ACV (weak) — — — — — 4
(Asteraceae)
Teclea simplifolia — — — — + ACV — — — — — 4
(Rutaceae)
Ternstroemia pringlei — Mexico fl ip + SIS — vv/am AE — — 47
Rose wr ME
(Theaceae) vt/igp
Tetrapleura tetraptera — Africa fr ip + LIS — vv/am VO — — 54
(Mimosaceae) (west coast)
Thalictrum thumbergii — — — — Antagonizes — — — — — 4
(Ranunculaceae) Phenamine
Excitation
Thalictrum hernandezii — — — — + ACV — — Hernandezine — — 4
(Ranunculaceae)
Trema guineensis — Gabon lf ip + PZIC — vv/m EE HP ↑ HA 55
(Ulmaceae) −MIS, PIC of PB
& KAIC
Trema orientalis — — — — +MIS — — Flavonoidal CNSD — 4
(Ulmaceae) mixture
Uncaria sinensis — — — — + ACV — — — — — 4
(Rubiaceae)
Valeriana officinalis — — — — — — — — CNSS AR 4
(Valerianaceae)
Veratrum viride — — — — + ACV — — Veratrone- — — 4
(Liliaceae) MgSO4
Vinca erecta — — — — + ACV — Ervinine — — 4
(Apocynaceae)
Xylopia spp. including: — Brazil — — − LIS & SIS — — — — — 5
X. aethiopica A. Rich
X. carminativa Fries
X. frustescens Aubl.
X. grandiflora St. Hil.
X. seriacea St. Hil.
(Annonaceae)
Zea mays L. — — — — −LIS, SIS — — — CNSD, S — 5
(Gramineae)
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Table 2: Clinical efficacy of four Chinese herbal treatments for epilepsy.
Treatment Efficacy
No. Markedly Effective Poorly Ineffective Aggravated
effective effective
1 100 72% 12% 10% 6% 0%
Control 40 72.5% 20% 5% 2.5% 0%
2 32 66% 25% 9% 0%
3A or 3B 239 65.7 29.7 1.7% 2.9% 0%
Treatment 1. From Chen et al.56: Tablet: Semen Persicae 30 g, Radix Paeoniae Rubra 15 g, Flos Carthami 15 g, Rhizoma Ligustici
Chuanxiong 15 g, Rhizoma Pinelliae 10 g, Rhizoma Cyperi 15 g, Medulla Tetrapanacis 8 g, Fructus Perillae 10 g, Pericarpium Citri
Reticulatae Viride 15 g, Radix Glycyrrhizae 10 g, Pericarpium Citri Reticulatae 15 g, Pericarpium Arecae 10 g, and Cortex Mori Radicis 15 g.
Dose: 1/2 tablet per kg body weight three times a day.
Control: Patients were treated with conventional western medicines but were not specified by the authors.
Treatment 2. From Kuang et al.57: ‘Qingyangshen’ decoction: Root of Cynanchum otophyllum 10–30 g daily in two divided doses.
Treatment 3. From Wang58: Zhenxianling
A) Oral tablet: peach flower buds, yellow-flower patrinia, Rhizoma Valerianae, Radix Salviae Militorrhizae, concentrated powder of ox horn,
pearl powder, Antelope’s horn powder, earth-worm, human placenta and Borneolum. The extract of the above components was concentrated,
dried and made into tablets of 0.45 g each.
Dose: 1–3 tablets twice a day.
B) Plaster: peach flower buds, yellow Daphne genkwa, Arisaema cum Bile, white dead silkworm, Radix Salviae Militorrhizae, Semen
Strychni, Semen Hyoscyami and Cynanchum otophyllum Scnneid, which were mixed with sesame oil and boiled down by the slow fire. After
the residuals infiltrated, the oil was set again on the fire and boiled down into syrup-like material which was then mixed with the yellow lead
and finally put on a piece of kraft paper to make the adhesive plaster.
Dose: The plaster was placed on acupoint Shenque (Ren 8 exactly at the centre of the umbilicus), and changed every 3 days.
Markedly effective: Number of attacks reduced by ≥ 75%
Effective: Number of attacks reduced by ≥ 50% and < 75%
Poorly effective: Number of attacks reduced by ≥ 25% and < 50%
Ineffective: Number of attacks reduced by < 25%
Aggravated: Number of attacks increased.
critically on the nature of the study, the questions
posed, and hence the kinds of samples, recordings or
observations required. However, for the drug screen-
ing, the models have to be simple and cheap to admin-
ister. It is out of the scope of this article to fully discuss
every available method, excellence reviews have been
conducted by Fisher (1989)59, Jefferys (1994)60 and
Meldrum (1997)61. In this review we will only briefly
mention the most common methods for evaluating the
antiepileptic drugs in preclinical studies.
In vivo studies. Various chemicals have been shown
to induce seizure in animals, different amount and dif-
ferent location of application will induce different type
of seizures. Practically, any stimuli which are suffi-
ciently strong to trigger off epileptic discharge in ani-
mal brain will trigger off seizures, thus, readers should
not be too surprised to see so many methods to induce
seizure in animal models. Table 3 is a summary of the
most commonly used methods.
In vitro studies. In vitro studies now have a central
role in fundamental studies of the epilepsies because
they can help to unravel cellular mechanisms. The ba-
sic principle of the in vitro methods is to target on
the mechanisms of seizure generation and propagation
mentioned in the previous sections. Brain slices, tis-
sue culture or neurones can be used for the study of
antiepileptic effects of different drugs.
The most popular techniques used in in vitro studies
are:
(1) Multichannel intracellular recordings to study
local circuit.
(2) Voltage clamp to study membrane currents.
(3) Patch clamp to study individual channel, e.g.
sodium channel.
(4) Binding to the neurotransmitters receptors
and the enzyme involved in transmitters
metabolism, e.g. GABA receptors and/or
GABA transaminase binding.
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Table 3: Common methods used to induce seizures in animal models.








(B) Acute electrical stimulation of cortical tissue
(C) GABA withdrawal
(2) Models for chronic simple partial seizures:
(A) Cortically implanted metal
(B) Crytogenic injury
(C) Ganglioside antibody injection
(3) Models for complex partial seizure:
(A) Kainic acid
(B) Tetanus toxin
(C) Injections into area tempesta
(D) Kindling model
(4) Models for generalized tonic–clonic seizures:
(A) Genetic
(i) Photosensitive baboons
(ii) Audigenic seizure mice
(iii) Totterer mice and other seizure-prone mouse strains





(iii) Other: picrotoxin, bicuculline, methionine, sulfoximine, strychnine
(D) Metabolic derangements
(5) Models for absence seizures:
(A) Thalamic stimulation





(G) Genetic rodent models of absence
(6) Status epilepticus
Large amounts of NMDA, Kainic acid, bicuculline, pentylenetetrazole.
(5) Change in the concentration of neurotransmit-
ters or their metabolites, e.g. glutamate and glu-
tamine.
Plants as a source for new antiepileptic
compounds
Table 1 summarized those plants/herbal preparations
which have been tested or reported for their in vivo/in
vitro antiepileptic/anticonvulsant activities in the past
30 years. Among those plants tested, a number of them
(from different families) are found to possess anticon-
vulsant activity. While in most cases, the active con-
stituents are yet to be found, for those where the ac-
tive components are known, they belong to different
chemical classes. However, previous studies showed
that some natural plant coumarins and triterpenoids
exhibit anticonvulsant properties62, 63.
Plants which warrant further investigations with re-
gards to their anticonvulsant effects are those which
have previously been shown to possess the activity,
however, the active constituent(s) is not known and the
plant is easily available and has low toxicity. From Ta-
ble 1, plants which fit into the above criteria include:
Albizia lebbek, Casimiroa edulis, Egletes viscosa, Ipo-
moea stans, Piper guineense, Piper nigrum, Psidium
guyanensis, Ruta chalepensis, Ternstroemia pringlei
and Tetrapleura tetraptera.
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Clinical data of traditional herbal medicines
Since most of the herbal medicines have been used for
a long time without testing, it is very difficult to find
sufficient clinical evidence to support their clinical ef-
ficacy. In fact, very few clinical studies using herbal
medicines were found with regards to the treatment of
epilepsy. Four literatures were identified to report the
effectiveness of four traditional Chinese herbal med-
ications56–58 and one Japanese herbal medication64.
Among these studies, none of them were randomized
double blind placebo-controlled clinical trials. There-
fore, it is difficult to prove whether the reduction
in the seizures was due to placebo effect or sponta-
neous seizure change. These phenomena also occur in
western medicines. For example, a randomized double
blind placebo-controlled clinical trial of gabapentin (a
new antiepileptic drug) shows about 10% of patients
with refractory epilepsy experienced 50% reduction in
the seizure.
Four Chinese herbal medications have shown im-
pressive clinical results (see Table 2); however, read-
ers must bear in mind the underlying methodological
problems in these studies. These herbal medications
are warrant to be subjected to more vigorous clinical
trials in the hope of finding more effective treatments.
The Japanese treatment was not included in Table 2
since the primary objective of the study was not to test
the efficacy in the treatment of epilepsy. Nevertheless,
it is interesting to note that the plant Cynanchum oto-
phyllum is present in two of these Chinese herbal treat-
ments (treatments 2 and 3B). However, no other stud-
ies are found to report its antiepileptic activity. Thus,
this plant is certainly of interest for further scientific
investigations with regards to its possible antiepileptic
effects.
CONCLUSION
The present article reveals that plant species from a
wide range of families have been shown to exhibit sig-
nificant in vivo/in vitro antiepileptic activities. Among
these plants, a number of active components belonging
to various chemical classes have been isolated. How-
ever, the active components of many of these plants
are still remained to be found. Thus, it is the wish of
the authors that this review article will stimulate the
interests in further investigations into natural products
for new antiepileptic agents.
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